APPLICATION
ANDA208201
TYPE
ANDA
ORIGINAL APPROVAL
2019-04-10
LATEST ACTION
2021-11-12
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
NAFTIFINE HYDROCHLORIDEPrescription
NAFTIFINE HYDROCHLORIDE 2% · GEL · TOPICAL
Approval history
2021-11-12Labeling · Supplement 3 · standardAP
2019-10-28Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.